Flowchart for the recruitment process of study participants.
<p>Flowchart for the recruitment process of study participants.</p>
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1852015124125057024 |
|---|---|
| author | Chitalu Chanda (21354901) |
| author2 | Webster C. Chewe (22566926) Benson M. Hamooya (9989739) Lukundo Siame (19484912) Matenge Mutalange (21354898) Aliness Dombola (22566929) Nyuma Mbewe (19198417) Chisha Sinyangwe (22566932) Melvin Mwansa (21433225) Duncan Chanda (8431107) |
| author2_role | author author author author author author author author author |
| author_facet | Chitalu Chanda (21354901) Webster C. Chewe (22566926) Benson M. Hamooya (9989739) Lukundo Siame (19484912) Matenge Mutalange (21354898) Aliness Dombola (22566929) Nyuma Mbewe (19198417) Chisha Sinyangwe (22566932) Melvin Mwansa (21433225) Duncan Chanda (8431107) |
| author_role | author |
| dc.creator.none.fl_str_mv | Chitalu Chanda (21354901) Webster C. Chewe (22566926) Benson M. Hamooya (9989739) Lukundo Siame (19484912) Matenge Mutalange (21354898) Aliness Dombola (22566929) Nyuma Mbewe (19198417) Chisha Sinyangwe (22566932) Melvin Mwansa (21433225) Duncan Chanda (8431107) |
| dc.date.none.fl_str_mv | 2025-11-05T18:31:42Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pgph.0005417.g001 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Flowchart_for_the_recruitment_process_of_study_participants_/30544496 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Biotechnology Sociology Science Policy Infectious Diseases Virology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified findings highlight opportunities antiretroviral therapy contribute 692 – 106 viral rebound occurred high viral loads high viral load university teaching hospital level health facilities enhanced adherence support enhanced adherence counseling unsuppressed viral loads achieved viral suppression achieve viral suppression zambia remain limited st </ sup major factor associated eac modestly improves div >< p never received mmd 12 months post among 386 participants three months post viral suppression level hospital 12 months three months received eac poor adherence improve adherence unsuppressed vl maintaining suppression targeted intervention prior enrollment primary outcome poisson regression people living month multi month mmd month dispensing integrate technology increased likelihood eac outcomes eac delivered december 2023 baseline demographic based delivery associated factors 600 copies 200 copies 000 ). |
| dc.title.none.fl_str_mv | Flowchart for the recruitment process of study participants. |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Flowchart for the recruitment process of study participants.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_892e9151c58b755dced4cef07f100c7f |
| identifier_str_mv | 10.1371/journal.pgph.0005417.g001 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30544496 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Flowchart for the recruitment process of study participants.Chitalu Chanda (21354901)Webster C. Chewe (22566926)Benson M. Hamooya (9989739)Lukundo Siame (19484912)Matenge Mutalange (21354898)Aliness Dombola (22566929)Nyuma Mbewe (19198417)Chisha Sinyangwe (22566932)Melvin Mwansa (21433225)Duncan Chanda (8431107)MedicineBiotechnologySociologyScience PolicyInfectious DiseasesVirologyEnvironmental Sciences not elsewhere classifiedBiological Sciences not elsewhere classifiedfindings highlight opportunitiesantiretroviral therapy contribute692 – 106viral rebound occurredhigh viral loadshigh viral loaduniversity teaching hospitallevel health facilitiesenhanced adherence supportenhanced adherence counselingunsuppressed viral loadsachieved viral suppressionachieve viral suppressionzambia remain limitedst </ supmajor factor associatedeac modestly improvesdiv >< pnever received mmd12 months postamong 386 participantsthree months postviral suppressionlevel hospital12 monthsthree monthsreceived eacpoor adherenceimprove adherenceunsuppressed vlmaintaining suppressiontargeted interventionprior enrollmentprimary outcomepoisson regressionpeople livingmonth multimonth mmdmonth dispensingintegrate technologyincreased likelihoodeac outcomeseac delivereddecember 2023baseline demographicbased deliveryassociated factors600 copies200 copies000 ).<p>Flowchart for the recruitment process of study participants.</p>2025-11-05T18:31:42ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1371/journal.pgph.0005417.g001https://figshare.com/articles/figure/Flowchart_for_the_recruitment_process_of_study_participants_/30544496CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/305444962025-11-05T18:31:42Z |
| spellingShingle | Flowchart for the recruitment process of study participants. Chitalu Chanda (21354901) Medicine Biotechnology Sociology Science Policy Infectious Diseases Virology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified findings highlight opportunities antiretroviral therapy contribute 692 – 106 viral rebound occurred high viral loads high viral load university teaching hospital level health facilities enhanced adherence support enhanced adherence counseling unsuppressed viral loads achieved viral suppression achieve viral suppression zambia remain limited st </ sup major factor associated eac modestly improves div >< p never received mmd 12 months post among 386 participants three months post viral suppression level hospital 12 months three months received eac poor adherence improve adherence unsuppressed vl maintaining suppression targeted intervention prior enrollment primary outcome poisson regression people living month multi month mmd month dispensing integrate technology increased likelihood eac outcomes eac delivered december 2023 baseline demographic based delivery associated factors 600 copies 200 copies 000 ). |
| status_str | publishedVersion |
| title | Flowchart for the recruitment process of study participants. |
| title_full | Flowchart for the recruitment process of study participants. |
| title_fullStr | Flowchart for the recruitment process of study participants. |
| title_full_unstemmed | Flowchart for the recruitment process of study participants. |
| title_short | Flowchart for the recruitment process of study participants. |
| title_sort | Flowchart for the recruitment process of study participants. |
| topic | Medicine Biotechnology Sociology Science Policy Infectious Diseases Virology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified findings highlight opportunities antiretroviral therapy contribute 692 – 106 viral rebound occurred high viral loads high viral load university teaching hospital level health facilities enhanced adherence support enhanced adherence counseling unsuppressed viral loads achieved viral suppression achieve viral suppression zambia remain limited st </ sup major factor associated eac modestly improves div >< p never received mmd 12 months post among 386 participants three months post viral suppression level hospital 12 months three months received eac poor adherence improve adherence unsuppressed vl maintaining suppression targeted intervention prior enrollment primary outcome poisson regression people living month multi month mmd month dispensing integrate technology increased likelihood eac outcomes eac delivered december 2023 baseline demographic based delivery associated factors 600 copies 200 copies 000 ). |